DCF — PALESTINE REGIONAL MEDICAL CENTER
Enterprise Value: $8.1M
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$8.1M
Enterprise Value
$0.0M
PV of Cash Flows
$8.0M
PV of Terminal Value
$12.9M
Terminal Value
10.0%
WACC
2.5%
Terminal Growth
Cash Flow Projections
PROJ| Year | Revenue | EBITDA | Margin | FCF | PV(FCF) |
|---|---|---|---|---|---|
| Year 1 | $93.5M | $3.0M | 3.0% | $-1.1M | $-1.0M |
| Year 2 | $96.3M | $4.1M | 4.0% | $-0.4M | $-0.3M |
| Year 3 | $99.2M | $5.2M | 5.0% | $0.3M | $0.3M |
| Year 4 | $102.1M | $5.9M | 6.0% | $0.7M | $0.5M |
| Year 5 | $105.2M | $6.3M | 6.0% | $0.9M | $0.6M |
Interpretation
INTAt a WACC of 10.0% and terminal growth of 2.5%, enterprise value is $8.1M. Terminal value accounts for 100% of total EV — consider sensitivity to terminal assumptions.
Next steps: Check the LBO model to see equity returns at this entry price, or the EBITDA bridge to model value creation levers.
Assumptions
ASSMrevenue base$90.7M
revenue growth rates[0.03, 0.03, 0.03, 0.03, 0.03]
ebitda margin base0.027612596363824873
ebitda margin improvement bps[50, 100, 100, 50, 25]
capex pct revenue0.04
nwc pct revenue0.08
tax rate0.25
projection years5